These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Teneligliptin Prevents Cardiomyocyte Hypertrophy, Fibrosis, and Development of Hypertensive Heart Failure in Dahl Salt-Sensitive Rats. Yamamoto M, Ishizu T, Seo Y, Suto Y, Sai S, Xu D, Murakoshi N, Kimura T, Kawakami Y, Aonuma K. J Card Fail; 2018 Jan; 24(1):53-60. PubMed ID: 28888840 [Abstract] [Full Text] [Related]
23. Combined effects of ramipril and angiotensin II receptor blocker TCV116 on rat congestive heart failure after myocardial infarction. Tao ZW, Huang YW, Xia Q, Xu QW. Chin Med J (Engl); 2005 Jan 20; 118(2):146-54. PubMed ID: 15667801 [Abstract] [Full Text] [Related]
27. Angiotensin II receptor antagonist TCV-116 induces regression of hypertensive left ventricular hypertrophy in vivo and inhibits the intracellular signaling pathway of stretch-mediated cardiomyocyte hypertrophy in vitro. Kojima M, Shiojima I, Yamazaki T, Komuro I, Zou Z, Wang Y, Mizuno T, Ueki K, Tobe K, Kadowaki T. Circulation; 1994 May 20; 89(5):2204-11. PubMed ID: 8181146 [Abstract] [Full Text] [Related]
28. [Comparison of candesartan, enalapril and their combination in congestive heart failure]. Rapezzi C. Ital Heart J Suppl; 2000 Mar 20; 1(3):429-30. PubMed ID: 10815278 [No Abstract] [Full Text] [Related]
29. Effects of angiotensin-converting enzyme inhibitor and angiotensin type 1 receptor antagonist in deoxycorticosterone acetate-salt hypertensive mice lacking Ren-2 gene. Peng H, Carretero OA, Alfie ME, Masura JA, Rhaleb NE. Hypertension; 2001 Mar 20; 37(3):974-80. PubMed ID: 11244026 [Abstract] [Full Text] [Related]
34. Synergistic attenuation of myocardial fibrosis in spontaneously hypertensive rats by joint treatment with benazepril and candesartan. Meng G, Wu F, Yang L, Zhu H, Gu J, He M, Xu J. J Cardiovasc Pharmacol; 2009 Jul 20; 54(1):16-24. PubMed ID: 19487956 [Abstract] [Full Text] [Related]
35. Temocapril prevents transition to diastolic heart failure in rats even if initiated after appearance of LV hypertrophy and diastolic dysfunction. Sakata Y, Yamamoto K, Mano T, Nishikawa N, Yoshida J, Miwa T, Hori M, Masuyama T. Cardiovasc Res; 2003 Mar 20; 57(3):757-65. PubMed ID: 12618237 [Abstract] [Full Text] [Related]